exRNAdisease

General Information

Database ID:

exR0410524

RNA Name:

NUTM2A-AS1

RNA Type:

lncRNA

Chromosome:

chr10

Starnd:

Coordinate:

Start Site(bp):

87201647

End Site(bp):

87342612

External Links:

Disease Information

Disease Name:	Clear Cell Renal Cell Carcinoma
Disease Category:	Cancers
MeSH ID:	D002292
Type:	Neoplasms/Urogenital Neoplasms
Alias:	Carcinoma, Renal Cell//Carcinomas, Renal Cell//Renal Cell Carcinomas//Adenocarcinoma, Renal Cell//Adenocarcinomas, Renal Cell//Renal Cell Adenocarcinoma//Renal Cell Adenocarcinomas//Adenocarcinoma Of Kidney//Adenocarcinoma Of Kidneys//Kidney, Adenocarcinoma Of//Kidneys, Adenocarcinoma Of//Renal Cell Cancer//Cancer, Renal Cell//Cancers, Renal Cell//Renal Cell Cancers//Adenocarcinoma, Renal//Adenocarcinomas, Renal//Renal Adenocarcinoma//Renal Adenocarcinomas//Nephroid Carcinoma//Carcinoma, Nephroid//Carcinomas, Nephroid//Nephroid Carcinomas//Renal Cell Carcinoma//Chromophobe Renal Cell Carcinoma//Sarcomatoid Renal Cell Carcinoma//Papillary Renal Cell Carcinoma//Renal Cell Carcinoma, Papillary//Chromophil Renal Cell Carcinoma//Clear Cell Renal Cell Carcinoma//Grawitz Tumor//Tumor, Grawitz//Clear Cell Renal Carcinoma//Carcinoma, Hypernephroid//Carcinomas, Hypernephroid//Hypernephroid Carcinoma//Hypernephroid Carcinomas//Hypernephroma//Hypernephromas//Collecting Duct Carcinoma (Kidney)//Carcinoma, Collecting Duct (Kidney)//Carcinomas, Collecting Duct (Kidney)//Collecting Duct Carcinomas (Kidney)//Collecting Duct Carcinoma of the Kidney//Renal Collecting Duct Carcinoma//Collecting Duct Carcinoma//Carcinoma, Collecting Duct//Carcinomas, Collecting Duct//Collecting Duct Carcinomas

Expression Detail

GEO ID:	GSE125442
Description:	Urinary exosomal long noncoding RNAs may be novel biomarkers for the diagnosis of clear cell renal cell carcinoma
Experimental Design:	Cancer vs Control
Case Disease Type:	Clear Cell Renal Cell Carcinoma
Case Disease SubType:	NA
Case Sample:	Clear Cell Renal Cell Carcinoma
Control Sample:	Healthy
Number of Case:	10
Number of Control:	10
Number of Samples:	20

Regulatory Relationship

mRNA targets:

miRNA targets:

miRNA Symbol	Chromosome	Start Site(bp)	End Site(bp)	Strand
hsa-miR-148b-3p	chr12	54337278	54337299	+
hsa-let-7a-5p	chr9	94175962	94175983	+
hsa-miR-4428	chr1	237471164	237471185	+
hsa-miR-4458	chr5	8460933	8460951	+
hsa-miR-107	chr10	89592756	89592778	-
hsa-miR-129-5p	chr7	128207876	128207896	+
hsa-let-7c-5p	chr21	16539838	16539859	+
hsa-miR-15a-5p	chr13	50049167	50049188	-
hsa-miR-376a-3p	chr14	101040825	101040845	+
hsa-miR-424-5p	chrX	134546680	134546701	-
hsa-miR-16-5p	chr3	160404754	160404775	+
hsa-miR-103a-3p	chr5	168560904	168560926	-
hsa-miR-139-5p	chr11	72615102	72615124	-
hsa-let-7d-5p	chr9	94178841	94178862	+
hsa-let-7b-5p	chr22	46113691	46113712	+
hsa-miR-488-3p	chr1	177029374	177029394	-
hsa-miR-148a-3p	chr7	25949922	25949943	-
hsa-let-7e-5p	chr19	51692793	51692814	+
hsa-miR-942-5p	chr1	117094655	117094676	+
hsa-let-7i-5p	chr12	62603691	62603712	+
hsa-miR-4524a-5p	chr17	69099606	69099627	-
hsa-miR-6884-5p	chr17	40026383	40026404	-
hsa-miR-4524b-5p	chr17	69099570	69099590	+
hsa-miR-548o-3p	chr20	38516607	38516628	+
hsa-miR-4500	chr13	87618671	87618687	-
hsa-miR-409-5p	chr14	101065314	101065336	+
hsa-miR-485-5p	chr14	101055427	101055448	+
hsa-miR-6838-5p	chr7	44073407	44073428	-
hsa-miR-195-5p	chr17	7017667	7017687	-
hsa-miR-15b-5p	chr3	160404607	160404628	+

circRNA targets:

lncRNA targets:

lncRNA Symbol	Chromosome	Start Site(bp)	End Site(bp)	Strand
AL132656.3	chr10	79663192	79664786	+

Display:

Experiment Detail

GEO ID:	GSE125442
Sample Source:	Urine
Source Fraction:	Exosome
Platform:	GPL21290
Method:	NGS
Num of detected RNA Type:	1
Num of detected RNAs of this Type:	882
Sample treatment protocol:	Exosomes were isolated by ultracentrifugation from 50-ml urine samples.
RNA Extract protocol:	A MiRNeasy Serum/Plasma Kit (QIAGEN, Valencia, CA, USA) was used to extract RNA from urinary exosome samples in accordance with the manufacturer's protocol.
RNA library preparation protocol:	Fragmented RNA (the average length was approximately 200 bp) were subjected to first strand and second strand cDNA synthesis following by adaptor ligation and enrichment with a low-cycle according to instructions of NEBNext® Ultra™ RNA Library Prep Kit for Illumina (NEB, USA).

Reference